| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.00B | 22.76B | 22.18B | 16.45B | 14.65B | 15.32B |
| Gross Profit | 19.22B | 19.42B | 16.28B | 14.15B | 12.44B | 11.86B |
| EBITDA | 3.42B | 4.42B | 3.90B | 3.09B | 2.73B | 2.13B |
| Net Income | 2.30B | 2.88B | 2.86B | 2.11B | 1.72B | 1.39B |
Balance Sheet | ||||||
| Total Assets | 25.83B | 23.47B | 20.76B | 20.20B | 18.42B | 16.89B |
| Cash, Cash Equivalents and Short-Term Investments | 17.93B | 16.19B | 12.89B | 15.53B | 14.46B | 12.59B |
| Total Debt | 3.60B | 1.60B | 0.00 | 2.50B | 2.02B | 2.03B |
| Total Liabilities | 5.57B | 4.89B | 3.70B | 5.19B | 4.58B | 4.16B |
| Stockholders Equity | 18.47B | 18.04B | 16.64B | 14.85B | 13.67B | 12.61B |
Cash Flow | ||||||
| Free Cash Flow | 1.43B | 0.00 | 3.65B | 24.15M | 105.91M | 3.21B |
| Operating Cash Flow | 1.65B | 0.00 | 3.81B | 199.92M | 217.10M | 3.32B |
| Investing Cash Flow | 275.78M | -793.21M | 315.12M | -265.51M | -86.30M | 23.93M |
| Financing Cash Flow | 1.13B | 87.67M | -3.76B | -523.05M | -765.21M | 767.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥24.16B | 16.33 | ― | 3.50% | 15.91% | 36.39% | |
72 Outperform | ¥112.77B | 16.22 | ― | 3.44% | 10.28% | -20.11% | |
71 Outperform | ¥733.75B | 28.67 | ― | 1.30% | 25.07% | 26.47% | |
71 Outperform | ¥22.19B | 8.70 | ― | 2.18% | 17.87% | 5.31% | |
64 Neutral | ¥31.54B | 31.60 | ― | 4.39% | 2.46% | -31.77% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥62.39B | 34.13 | ― | 2.96% | 10.63% | 7.42% |